ODDB.org: Open Drug Database

Vertex Pharmaceuticals (CH) GmbH - Trikafta 80 mg / 40 mg / 60 mg, 59.5 mg, Granulat

Swissmedic Registration	69212	Sequence	02
Product name	Trikafta 80 mg / 40 mg / 60 mg, 59.5 mg	Description	Granulat
ATC-Classification	R07AX32	ATC-Description	Ivacaftor, Tezacaftor and Elexacaftor
Introduction of Sequence	13.06.2024

Composition

Granulat Morgendosis (elexacaftorum 80 mg / tezacaftorum 40 mg / ivacaftorum 60 mg): elexacaftorum 80 mg, tezacaftorum 40 mg, ivacaftorum 60 mg, hypromellosum, hypromellosi acetas succinas, natrii laurilsulfas, lactosum monohydricum 188.6 mg, mannitolum, carmellosum natricum conexum, sucralosum, magnesii stearas, silica colloidalis anhydrica, ad granulatum pro charta corresp. natrium max. 2.75 mg. Granulat Abenddosis (ivacaftorum 59.5 mg): ivacaftorum 59.5 mg, hypromellosi acetas succinas, natrii laurilsulfas, lactosum monohydricum 87.3 mg, mannitolum, carmellosum natricum conexum, sucralosum, magnesii stearas, silica colloidalis anhydrica, ad granulatum pro charta corresp. natrium max. 1.18 mg.

Packungsbestandteile

Galenic Form

Granulate

Excipiens

Active Agent	Dose
	80 mg
	60 mg
	40 mg

BAG: Active Agent	Dose
	80 mg
	59.5 mg
	40 mg

Inactive agents	Dose



Hypromellosum
Lactose Monohydrate	188.6 mg

Mannitol

Silica Colloidalis Anhydrica

Galenic Form

Granulate

Excipiens

Active Agent	Dose
	59.5 mg

BAG: Active Agent	Dose
	80 mg
	59.5 mg
	40 mg

Inactive agents	Dose



Lactose Monohydrate	87.3 mg

Mannitol

Silica Colloidalis Anhydrica

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	56	13896.18	14565.30	A	SL	No

2025	©ywesee GmbH